enzalutamide

Italy

Drugs containing this active substance

  • ENZALUTAMIDE ACCORD

    It is used for the treatment of adult men with prostate cancer who no longer respond to hormone therapy or surgical treatment to reduce testosterone, or who have widespread disease in other parts of the body but respond to such therapies.

    Form: capsules, soft gelatin

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • ENZALUTAMIDE EG

    It is used for the treatment of adult men with prostate cancer that no longer responds to hormonal or surgical therapy, has spread to other parts of the body, or shows a rapid increase in PSA after previous treatments.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: EG S.P.A.

  • ENZALUTAMIDE SANDOZ

    It is used for the treatment of adult men with prostate cancer who no longer respond to hormone therapy or surgical treatment to reduce testosterone, or who have widespread disease in other parts of the body but respond to such treatments.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: SANDOZ S.P.A.

  • ENZALUTAMIDE SANDOZ GMBH

    It is used for the treatment of adult men with prostate cancer that no longer responds to hormone therapy or surgical treatment to reduce testosterone, which has spread to other parts of the body, or for those who have undergone prostate removal or radiotherapy and have a rapidly increasing PSA.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: SANDOZ GMBH

  • ENZALUTAMIDE VIATRIS

    It is used for the treatment of adult men with prostate cancer that no longer responds to hormonal therapy or surgical treatment, which has spread to other parts of the body, or for those who have undergone prostate removal or radiotherapy and present a rapid increase in PSA.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: VIATRIS LIMITED

  • ENZALUTAMIDE ZENTIVA

    It is used for the treatment of adult men with prostate cancer that no longer responds to hormonal therapy or surgical treatment and has spread to other parts of the body, or for those who have undergone prostate removal or radiotherapy and show a rapid increase in PSA.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • MIDAMID

    It is used for the treatment of adult men with prostate cancer that no longer responds to hormonal therapy or surgical treatment, or for those with widespread disease that responds to such therapies, or for those who have undergone prostate removal or radiotherapy and present a rapid increase in PSA.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: FARMITALIA INDUSTRIA CHIMICO FARMACEUTICA S.R.L.

  • MIDANEX

    Midanex is indicated for the treatment of adult men with prostate cancer who no longer respond to hormonal or surgical therapy, who have widespread disease but respond to hormonal therapy, or who have undergone prostatectomy or radiotherapy with a rapid increase in PSA.

    Form: tablets, film-coated

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: FARMITALIA INDUSTRIA CHIMICO FARMACEUTICA S.R.L.

  • XTANDI

    It is used for the treatment of adult men with prostate cancer that no longer responds to hormonal or surgical therapy, which has spread to other parts of the body, or who show a rapid increase in PSA after previous prostate removal or radiotherapy.

    Form: capsules, soft gelatin

    Active substance Dosage
    enzalutamide -

    ATC: L02BB04

    Manufacturer: ASTELLAS PHARMA EUROPE B.V.